The development of robust clinical trial methodologies increasingly relies on advanced statistical frameworks for model selection and the characterisation of dose–response relationships. With modern ...
We consider problems in model selection caused by the geometry of models close to their points of intersection. In some cases—including common classes of causal or graphical models, as well as time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback